Variable | Overall population n = 22 | Converters n = 9 | Non-converters n = 13 | p-value |
---|---|---|---|---|
Age (years) – Med(IQR) | 33(29–40) | 32(29–40) | 36 (30–39) | 0.52 |
Sex - Female | 90.9 % | 100 % | 84.6 % | 0.49 |
CD4 count (/mm3) – Med(IQR) | 477 (439 – 621) | 466 (426–720) | 477 (458–589) | 0.87 |
On ART | 73 % | 66.6 % | 76.9 % | 0.66 |
Previous TB treatment | 31.8 % | 23.1 % | 44.4 % | 0.37 |
Time between tests (days) – Med(IQR) | 62 (49–70) | 50 (46–62) | 69 (58–71) | 0.11 |
Baseline TBAg-Nil (IU/ml) – Med (IQR) | 0.07 (0.01–0.21) | 0.21 (0.17–0.26) | 0.02 (0.01–0.07) | 0.002 |
Change in TBAg-Nil (IU/ml) – Med(IQR) | 0.09 (−0.05–0.62) | 0.82 (0.39–1.28) | 0.03 (−0.05–0.06) | 0.0001 |